# EDGAR Filing Document

**Accession Number:** 0000842633
**File Stem:** 0000842633-26-000004
**Filing Date:** 2026-2
**Character Count:** 70501
**Document Hash:** 9c190a9460423077c8a86ac5dd0b97f4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000842633-26-000004.hdr.sgml**: 20260226

**ACCESSION NUMBER**: 0000842633-26-000004

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260226

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260226

**DATE AS OF CHANGE**: 20260226

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TRIMAS CORP
- **CENTRAL INDEX KEY:** 0000842633
- **STANDARD INDUSTRIAL CLASSIFICATION:** METAL FORGING & STAMPINGS [3460]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 382687639
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-10716
- **FILM NUMBER:** 26682112

**BUSINESS ADDRESS:**
- **STREET 1:** 38505 WOODWARD AVENUE
- **STREET 2:** SUITE 200
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48304
- **BUSINESS PHONE:** 2486315400

**MAIL ADDRESS:**
- **STREET 1:** 38505 WOODWARD AVENUE
- **STREET 2:** SUITE 200
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48304

?xml version='1.0' encoding='ASCII'? trs-20260226

---

| |
|:---|
| **UNITED STATES** |
| **SECURITIES AND EXCHANGE COMMISSION** |
| **Washington, D.C. 20549** |

---

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported) February 26, 2026

**TRIMAS CORPORATION** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-10716** | **38-2687639** |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |

---

---

| | | | |
|:---|:---|:---|:---|
| **38505 Woodward Avenue,** | **Suite 200,** | **Bloomfield Hills,** | **48304** |
| **Michigan** | **Michigan** | **Michigan** | |
| (Address of principal executive offices) | (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code **(248) 631-5450** 

**Not Applicable**

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading symbol(s)</u>** | **<u>Name of exchange on which registered</u>** |
| Common stock, $0.01 par value | TRS | The NASDAQ Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

TriMas Corporation (the "Corporation") issued a press release on February 26, 2026, reporting its financial results for the fourth quarter and year ended December 31, 2025. A copy of the press release is attached hereto as an exhibit and is incorporated herein by reference. The press release is also available on the Corporation's website at <u>www.trimas.com</u>.

The information furnished pursuant to this Item 2.02, including Exhibits 99.1 and 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Corporation under the Securities Act of 1933 or the Exchange Act.

**Item 9.01 Financial Statements and Exhibits.**

(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits. The following exhibits are furnished herewith:

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 99.1 | <u>[Press Release](trs_123125xexhibit991.htm)</u> |
| 99.2 | <u>[Supplemental Historical Information - Recast](trs_123125xexhibit992.htm)</u> |
| 104 | Cover Page Interactive File (embedded within the Inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | TRIMAS CORPORATION | TRIMAS CORPORATION |
| Date: | February 26, 2026 | By: | /s/ Paul A. Swart |
|  |  | Name: | Paul A. Swart |
|  |  | Title: | Chief Financial Officer |

---

## Exhibit 99.1

![trimas_logoxpantone-workivaa.jpg](trimas_logoxpantone-workivaa.jpg)

**TRIMAS REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Full-year and fourth quarter 2025 results in line with Company expectations*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Repurchased more than three million shares during fourth quarter; today announced an increase in share repurchase authorization*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Implemented cost reduction initiatives expected to generate $15 million in annualized savings*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Aerospace moved to Discontinued Operations; divestiture on track to close in first quarter 2026*

**BLOOMFIELD HILLS, Michigan, February 26, 2026** - TriMas (NASDAQ: TRS) today announced financial results for the fourth quarter and full year ended December 31, 2025.

**<u>Summary</u>**

*($ in millions, except per share amounts)*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** |
| | **As Reported** | **As Reported** | **As Reported** | **Adjusted**<sup>(12)</sup> | **Adjusted**<sup>(12)</sup> | **Adjusted**<sup>(12)</sup> |
|  | **2025** | **2024** | ***% Change*** | **2025** | **2024** | ***% Change*** |
| **Net sales** |  |  |  |  |  |  |
| TriMas Continuing Operations | $645.7 | $630.8 | *2.4%* | $645.7 | $630.8 | *2.4%* |
| Aerospace - Discontinued Operations | 396.4 | 294.2 | *34.7%* | 396.4 | 294.2 | *34.7%* |
| Total Company | $1042.2 | $925.0 | *12.7%* | $1042.2 | $925.0 | *12.7%* |
| **Operating profit** |  |  |  |  |  |  |
| TriMas Continuing Operations | $41.3 | $15.2 | *172.2%* | $34.4 | $47.0 | *(26.9)%* |
| Aerospace - Discontinued Operations | 67.0 | $32.0 | *109.2%* | 72.3 | 35.9 | *101.8%* |
| Total Company | $108.3 | $47.2 | *129.5%* | $106.7 | $82.8 | *28.8%* |
| **Income (loss)** |  |  |  |  |  |  |
| TriMas Continuing Operations | $72.3 | $(2.0) | *n/m* | $22.4 | $31.6 | *(29.1)%* |
| Aerospace - Discontinued Operations | 47.8 | 26.2 | *82.6%* | 62.8 | 36.1 | *73.9%* |
| Total Company | $120.1 | $24.3 | *395.4%* | $85.3 | $67.7 | *25.9%* |
| **Diluted earnings per share** |  |  |  |  |  |  |
| TriMas Continuing Operations | $1.78 | $(0.05) | *n/m* | $0.55 | $0.77 | *(28.6)%* |
| Aerospace - Discontinued Operations | 1.17 | $0.65 | *80.0%* | $1.54 | $0.88 | *75.0%* |
| Total Company | $2.95 | $0.60 | *391.7%* | $2.09 | $1.65 | *26.7%* |

---

"We finished 2025 with a solid performance at the upper end of our earnings per share guidance range, supported by continued strong top-line growth and disciplined execution across our businesses," said Thomas Snyder, TriMas President and Chief Executive Officer. "Since stepping into the CEO role last June, my focus has been on building momentum and positioning TriMas for its next chapter. Our previously announced Aerospace transaction continues to progress as planned, with completion expected in mid-to-late March. In parallel, we are realigning TriMas for the future, streamlining our operating structure, executing cost-out initiatives and creating a more agile, customer-centric organization. The proceeds of the Aerospace divestiture will enable us to invest in our business, expand further into attractive packaging and life sciences opportunities, accelerate value creation and deliver compelling long-term returns for our shareholders."

**<u>Total Company Results</u>** *<u>(Before Consideration of Discontinued Operations)</u>*

TriMas reported full year 2025 total company net sales of $1,042.2 million, up 12.7% from 2024, with growth in the Packaging and Aerospace groups. Operating profit increased to $108.3 million, compared to $47.2 million in 2024. Adjusting for Special Items<sup>(1)</sup>, operating profit was $106.7 million, a 28.8% increase over $82.8 million in the prior year. TriMas total company full year 2025 net income was $120.1 million, or $2.95 per diluted share, compared to $24.3 million, or $0.60 per diluted share, in 2024. Total company 2025 adjusted net income<sup>(2)</sup> was $85.3 million, up

------

from $67.7 million in 2024. As a result, adjusted diluted earnings per share<sup>(2)</sup> increased 26.7% to $2.09, compared to $1.65 in the prior year, driven primarily by higher sales levels and continued operational improvement initiatives.

For fourth quarter 2025, total company net sales were $256.5 million, up 12.5% from $228.1 million in fourth quarter 2024. Fourth quarter 2025 operating profit was $42.8 million, compared to $8.6 million in fourth quarter 2024. Adjusting for Special Items<sup>(1)</sup>, operating profit was $20.2 million, compared to $23.2 million in fourth quarter 2024. TriMas reported total company net income of $81.7 million, or $2.03 per diluted share, compared to $5.6 million, or $0.14 per diluted share, in fourth quarter 2024. Fourth quarter 2025 adjusted net income<sup>(2)</sup> was $16.3 million, compared to $17.5 million in the prior year period. Adjusted diluted earnings per share<sup>(2)</sup> was $0.40, compared to $0.43 in fourth quarter 2024, primarily reflecting the timing and levels of incentive compensation between periods.

**<u>TriMas Aerospace Divestiture Update and Discontinued Operations</u>**

The previously announced sale of TriMas Aerospace (the "Transaction") to an affiliate of Tinicum L.P. and funds managed by Blackstone under the definitive agreement entered into on November 4, 2025, remains on track for completion. TriMas Aerospace is expected to be sold for approximately $1.45 billion in cash, subject to customary post-closing adjustments, resulting in estimated net after-tax proceeds of approximately $1.2 billion. The Company currently expects to use the proceeds to support organic growth investments, pursue strategically aligned acquisition opportunities and repurchase shares. The Company also plans to repay the borrowings outstanding on its revolving credit facility resulting from the recent share repurchase activity and hold the remaining proceeds in interest-bearing accounts until deployed.

Beginning in the fourth quarter of 2025, the Company began reporting the quarterly and full year results of TriMas Aerospace, previously included in the Aerospace segment, as Discontinued Operations. In addition, at closing, the parties will enter into a customary transition services agreement covering certain support services. Following completion of the Transaction, TriMas will operate in two segments: Packaging, representing the TriMas Packaging business, and the Specialty Products segment, which includes Norris Cylinder.

To provide historical information on a basis that reflects the planned sale of TriMas Aerospace, the Company has recast certain historical results, included as Exhibit 99.2 to the Form 8-K being filed today.

**<u>Results from Continuing Operations</u>**

For full year 2025, TriMas reported net sales from continuing operations of $645.7 million, an increase of 2.4% compared to 2024, as sales growth in the Packaging group was partially offset by a 7.0% decline in Specialty Products due to the Arrow Engine sale. Full year 2025 income from continuing operations was $72.3 million, or $1.78 per diluted share, compared to a loss of $2.0 million, or $0.05 per diluted share, in 2024. Adjusting for Special Items<sup>(1)</sup>, full year 2025 adjusted income<sup>(2)</sup> from continuing operations was $22.4 million, compared to $31.6 million in 2024. Adjusted diluted earnings per share<sup>(2)</sup> from continuing operations was $0.55, compared to $0.77 in the prior year, primarily reflecting the differences in timing and levels of incentive compensation between periods, as well as the lower operating profit related to the sale of Arrow Engine in early 2025.

For fourth quarter 2025, TriMas reported fourth quarter 2025 net sales from continuing operations of $155.5 million, an increase of 3.8% over $149.7 million in fourth quarter 2024, driven by continued growth in the Packaging group. TriMas reported income from continuing operations of $72.9 million, or $1.81 per diluted share, compared to a loss of $3.5 million, or $0.09 per diluted share, in fourth quarter 2024. Adjusting for Special Items<sup>(1)</sup>, adjusted income<sup>(2)</sup> from continuing operations was $1.6 million, compared to $7.1 million in the prior year period. Adjusted diluted earnings per share<sup>(2)</sup> from continuing operations was $0.04, compared to $0.17 in fourth quarter 2024.

**<u>Share Repurchases</u>**

During 2025, TriMas repurchased 3,124,866 shares of its outstanding common stock for $103.3 million, with more than three million of these shares repurchased since the announcement of the Aerospace divestiture. As of December 31, 2025, the Company had approximately $48.9 million remaining under its share repurchase authorization and approximately 37.6 million shares outstanding.

Today, the Company announced that its Board of Directors has increased its common stock share repurchase authorization to a total of up to $150 million, adding to the $48.9 million remaining under the previous authorization. The Board will continue to assess adding to the Company's existing share repurchase authorization.

------

**<u>Financial Position</u>**

The Company generated $41.5 million of net cash provided by operating activities in fourth quarter 2025, compared to $27.1 million in fourth quarter 2024. As a result, total company Free Cash Flow<sup>(3)</sup> for the quarter was $43.3 million, up from $16.8 million in fourth quarter 2024. On a full year basis, TriMas reported net cash provided by operating activities of $117.5 million, compared to $63.8 million for 2024. As a result, total company full year Free Cash Flow<sup>(3)</sup> was $87.2 million, an increase of 197.6% from $29.3 million in 2024, driven by improved operating performance and continued working capital discipline. Please see Appendix I for further details.

TriMas ended 2025 with $30.0 million of cash on hand, $205.2 million of cash and available borrowing capacity under its revolving credit facility, and a net leverage ratio of 2.7x as defined in its credit agreement. As of December 31, 2025, TriMas reported total debt of $469.2 million and Net Debt<sup>(4)</sup> of $439.2 million, including borrowings of $72.8 million under its revolving credit facility used primarily to fund share repurchases. As noted above, the Company expects to receive approximately $1.2 billion in net after-tax proceeds upon completion of the sale of TriMas Aerospace, which will significantly enhance liquidity and financial flexibility.

**<u>Fourth Quarter Segment Results</u>**

TriMas Packaging group reported fourth quarter net sales of $129.3 million, a 5.0% increase compared to fourth quarter 2024. Growth was primarily driven by higher demand for products for industrial and life science markets, and the benefit of favorable foreign currency exchange, partially offset by continued softer demand for closures and flexible packaging products used in food and beverage applications. Fourth quarter operating profit and margins declined year-over-year, primarily as a result of a less favorable sales mix.

TriMas' Specialty Products group reported fourth quarter net sales of $26.2 million, a slight decline of 1.4% compared to fourth quarter 2024, as a 13.8% year-over-year sales increase at Norris Cylinder was more than offset by the loss of sales related to the Arrow Engine divestiture in January 2025. Fourth quarter operating profit and margins improved over the prior year period, driven by the benefit of prior restructuring actions at Norris Cylinder, which helped offset the profit loss from the Arrow Engine sale.

TriMas Aerospace group, which is now reported in Discontinued Operations, generated fourth quarter net sales of $101.0 million, an increase of 28.9% compared to fourth quarter 2024. This strong growth was primarily driven by higher industry build rates, new contract awards, commercial actions and the first-quarter 2025 acquisition of TriMas Aerospace Germany (TAG). Fourth quarter operating profit and margins increased significantly over the prior year period, driven by improved sales conversion, commercial actions and operational excellence initiatives, even with incremental allocations related to the pending sale of the business.

**<u>Realignment and Cost-Out Initiatives</u>**

TriMas executed a comprehensive organizational realignment to streamline operations, strengthen customer responsiveness and drive sustainable cost savings. The realignment integrates select corporate and business functions to simplify the structure, eliminates duplication and improves operational efficiency. These initiatives are expected to generate more than $10 million in savings in 2026 and approximately $15 million on an annualized basis, with additional cost-reduction initiatives underway.

As part of this effort, TriMas Packaging is restructuring its commercial and operational model to eliminate silos, accelerate decision-making, and deliver more integrated customer solutions. The changes include unifying sales teams, standardizing operations across facilities and reducing management layers to improve speed, accountability and innovation. Key initiatives include brand unification, expanded operational excellence programs, technology implementations and manufacturing footprint optimization. Collectively, these actions are expected to strengthen TriMas' operating model, enhance customer satisfaction and support sustainable long-term value creation.

**<u>2026 Outlook</u>**

For 2026, the Company expects sales growth of 3% to 6% year-over-year across the combined Packaging and Specialty Products businesses. In addition, TriMas anticipates more than 300 basis points of adjusted operating profit margin improvement, driven by the cost reduction and organizational realignment initiatives underway. Additional assumptions and modeling considerations will be discussed on the earnings call later this morning.

"As we prepare to complete the sale of TriMas Aerospace, we are excited about the future of TriMas as a more focused and agile company. This transaction allows us to intensify our attention on our Packaging and Specialty Products businesses, both of which are well-positioned for continued growth and operational improvement. Our realignment and cost-out initiatives are already creating a stronger and more efficient foundation, and we expect these actions to drive meaningful margin expansion as we progress through 2026. We also look forward to deploying the Aerospace sale proceeds in ways that enhance long-term value for our shareholders, employees and

------

customers. Consistent with this approach, we expect to use the proceeds to support organic growth investments, pursue strategically aligned acquisition opportunities and repurchase shares," continued Snyder.

**<u>Conference Call Information</u>**

TriMas will host its fourth quarter and full year 2025 earnings conference call today, Thursday, February 26, 2026, at 10:00 a.m. ET. To participate via phone, please dial (877) 407-0890 (U.S. and Canada) or +1 (201) 389-0918 (outside the U.S. and Canada) and ask to be connected to the TriMas fourth quarter and full year 2025 earnings conference call. The conference call will also be simultaneously webcast via TriMas' website at <u>www.trimas.com</u>, under the "Investors" section, with an accompanying slide presentation. A replay of the conference call will be available on the TriMas website or by dialing (877) 660-6853 (U.S. and Canada) or +1 (201) 612-7415 (outside the U.S. and Canada) with a meeting ID of 13758505, beginning February 26, 2026, at 3:00 p.m. ET through March 12, 2026, at 3:00 p.m. ET.

**<u>Notice Regarding Forward-Looking Statements</u>**

The above outlook includes the impact of all announced acquisitions and divestitures as of February 26, 2026. All of the above amounts considered as 2026 guidance are after adjusting for any current or future amounts that may be considered Special Items. The inability to predict the amount and timing of the impacts of these Special Items makes a detailed reconciliation of these forward-looking non-GAAP financial measures impracticable.<sup>(1)</sup> 

Any "forward-looking" statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, contained herein, including those relating to TriMas' business, financial condition or future results, involve risks and uncertainties with respect to, including, but not limited to: general economic and currency conditions; competitive factors; market demand; our ability to realize our business strategies; government and regulatory actions, including, without limitation, the impact of current and future tariffs and reciprocal tariffs, quotas and surcharges, as well as climate change legislation and other environmental regulations; our ability to identify attractive acquisition candidates, successfully integrate acquired operations or realize the intended benefits of such acquisitions; our ability to successfully complete the planned sale of our TriMas Aerospace business ("TriMas Aerospace") within the expected time frame or at all; our ability to recognize the benefits of and effectively deploy the proceeds from the planned sale of TriMas Aerospace; pressures on our supply chain, including availability of raw materials and inflationary pressures on raw material and energy costs, and customers; the performance of our subcontractors and suppliers; risks and uncertainties associated with intangible assets, including goodwill or other intangible asset impairment charges; risks associated with a concentrated customer base; information technology and other cyber-related risks; risks related to our international operations, including, but not limited to, risks relating to tensions between the United States and China; changes to fiscal and tax policies; intellectual property factors; uncertainties associated with our ability to meet customers' and suppliers' sustainability and environmental, social and governance ("ESG") goals and achieve our sustainability and ESG goals in alignment with our own announced targets; litigation; contingent liabilities relating to acquisition and disposition activities; interest rate volatility; our leverage; liabilities imposed by our debt instruments; labor disputes and shortages; the disruption of operations from catastrophic or extraordinary events, including, but not limited to, natural disasters, geopolitical conflicts and public health crises; the amount and timing of future dividends and/or share repurchases, which remain subject to Board approval and depend on market and other conditions; our future prospects; and other risks that are detailed in the Annual Report on Form 10-K for the year ended December 31, 2024, and Part II, Item 1A, "Risk Factors," in our subsequent Quarterly Reports on Form 10-Q. The risks described are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deemed to be immaterial also may materially adversely affect our business, financial position and results of operations or cash flows. These risks and uncertainties may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements made herein are based on information currently available, and the Company assumes no obligation to update any forward-looking statements, except as required by law.

**<u>Non-GAAP Financial Measures</u>**

In this release, certain non-GAAP financial measures are used. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measure may be found in Appendix I at the end of this release. Management believes that presenting these non-GAAP financial measures provides useful information to investors by helping them identify underlying trends in the Company's businesses and facilitating comparisons of performance with prior and future periods and to the Company's peers. These non-GAAP financial measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.

------

Reconciliations of forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures are provided only for the expected impact of amortization of acquisition-related intangible assets for completed acquisitions, as the Company is unable to provide estimates of future Special Items<sup>(1)</sup> or amortization from future acquisitions without unreasonable effort, due to the uncertainty and inherent difficulty of predicting the occurrence and the financial impact of such items impacting comparability and the periods in which such items may be recognized. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

Additional information is available at <u>www.trimas.com</u> under the "Investors" section.

<sup>(1)</sup> Appendix I details certain costs, expenses and other amounts or charges, collectively described as "Special Items," that are included in the determination of net income, earnings per share and/or cash flows from operating activities under GAAP, but that management believes should be separately considered when evaluating the quality of the Company's core operating results, given they may not reflect the ongoing activities of the business.

<sup>(2)</sup> The Company defines adjusted net income (and on a per diluted share basis, adjusted diluted earnings per share) as net income (per GAAP), plus or minus the after-tax impact of Special Items<sup>(1)</sup>, plus the after-tax impacts of non-cash acquisition-related intangible asset amortization and non-cash compensation expense. While the acquisition-related intangible assets aid in the Company's revenue generation, the Company adjusts for the non-cash amortization expense and non-cash compensation expense because the Company believes it (i) enhances management's and investors' ability to analyze underlying business performance, (ii) facilitates comparisons of financial results over multiple periods, and (iii) provides more relevant comparisons of financial results with the results of other companies as the amortization expense associated with these assets may fluctuate significantly from period to period based on the timing, size, nature, and number of acquisitions. 

<sup>(3)&nbsp;&nbsp;&nbsp;&nbsp;</sup>The Company defines Free Cash Flow as Net Cash Provided by/Used for Operating Activities, excluding the cash impact of Special Items, less Capital Expenditures. Please see Appendix I for additional details. 

<sup>(4)</sup> The Company defines Net Debt as Total Debt less Cash and Cash Equivalents. Please see Appendix I for additional details.

**<u>About TriMas</u>**

**<u>Contact</u>**

Sherry Lauderback

VP, Investor Relations & Communications

(248) 631-5506

sherry.lauderback@trimas.com

------

**TriMas Corporation**

**Condensed Consolidated Balance Sheet** 

**(Unaudited, dollars in thousands)**

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2025** | **December 31,<br>2024** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $30020 | $23070 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables, net | 111270 | 115590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 108720 | 110440 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 36380 | 27260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current assets, held for sale | 176280 | 150280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 462670 | 426640 |
| Property and equipment, net | 247510 | 237700 |
| Operating lease right-of-use assets | 31800 | 32440 |
| Goodwill | 300280 | 287060 |
| Other intangibles, net | 76550 | 78390 |
| Deferred income taxes | 53670 | 10760 |
| Other assets | 45430 | 9410 |
| Non-current assets, held for sale | 267170 | 241780 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1485080 | $1324180 |
| **Liabilities and Shareholders' Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $72280 | $72350 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 59640 | 42760 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease liabilities, current portion | 4100 | 6000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current liabilities, held for sale | 47650 | 38320 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 183670 | 159430 |
| Long-term debt, net | 469170 | 398120 |
| Lease liabilities | 31810 | 30240 |
| Deferred income taxes | 17710 | 17580 |
| Other long-term liabilities | 65840 | 42170 |
| Non-current liabilities, held for sale | 11290 | 9340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 779490 | 656880 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 705590 | 667300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $1485080 | $1324180 |

---

------

**TriMas Corporation**

 **Consolidated Statement of Income**

 **(Unaudited, dollars in thousands, except share and per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended<br>December 31,** | **Three months ended<br>December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net sales | $155490 | $149730 | $645720 | $630800 |
| Cost of sales | (122580) | (127270) | (507560) | (501260) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 32910 | 22460 | 138160 | 129540 |
| Selling, general and administrative expenses | (38160) | (23020) | (129310) | (109650) |
| Asbestos-related benefit (costs), net | 35800 |  | 27770 | (5510) |
| Net gain (loss) on dispositions of assets | (610) | (10) | 4680 | 1020 |
| Impairment of indefinite-lived intangible assets |  | (230) |  | (230) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | 29940 | (800) | 41300 | 15170 |
| Other expense, net: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (4590) | (4550) | (18030) | (19560) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | (320) | 540 | 990 | 210 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (4910) | (4010) | (17040) | (19350) |
| Income (loss) before income tax expense | 25030 | (4810) | 24260 | (4180) |
| Income tax benefit | 47820 | 1290 | 48050 | 2230 |
| Income (loss) from continuing operations | 72850 | (3520) | 72310 | (1950) |
| Income from discontinued operations, net of income taxes | 8850 | 9160 | 47830 | 26200 |
| Net income | $81700 | $5640 | $120140 | $24250 |
| **Basic earnings (loss) per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $1.84 | $(0.09) | $1.79 | $(0.05) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | 0.22 | 0.23 | 1.18 | 0.65 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income per share | $2.06 | $0.14 | $2.97 | $0.60 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares - basic | 39633498 | 40573108 | 40384270 | 40725714 |
| **Diluted earnings (loss) per share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $1.81 | $(0.09) | $1.78 | $(0.05) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | 0.22 | 0.23 | 1.17 | 0.65 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income per share | $2.03 | $0.14 | $2.95 | $0.60 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares - diluted | 40148066 | 40573108 | 40790137 | 40725714 |

---

------

**TriMas Corporation**

 **Consolidated Statement of Cash Flows**

 **(Unaudited - dollars in thousands)**

---

| | | |
|:---|:---|:---|
| | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
| | **2025** | **2024** |
| **Cash Flows from Operating Activities:** |  |  |
| Income (loss) from continuing operations | $72310 | $(1950) |
| Income from discontinued operations | 47830 | 26200 |
| Net income | 120140 | 24250 |
| Adjustments to reconcile income to net cash provided by operating activities, net of acquisition impact: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment of indefinite-lived intangible assets |  | 230 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on dispositions of assets | (4510) | (1000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 39710 | 48120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangible assets | 17320 | 16800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issue costs | 950 | 960 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (37390) | (3240) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash compensation expense | 11540 | 6960 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for losses on accounts receivable | (1250) | (1000) |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related (benefit) costs, net | (27770) | 5510 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for environmental liabilities | 6500 | 3340 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in receivables | 1780 | (20520) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase in inventories | (4270) | (21200) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in prepaid expenses and other assets | 4050 | (2340) |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in accounts payable and accrued liabilities | (2360) | 560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating activities | (6990) | 6350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 117450 | 63780 |
| **Cash Flows from Investing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (48350) | (50960) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of businesses, net of cash acquired | (37730) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cross-currency swap terminations |  | (3760) |
| &nbsp;&nbsp;&nbsp;&nbsp;Settlement of foreign currency exchange forward contract |  | 3760 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from disposition of business, property and equipment | 22030 | 4000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used for investing activities | (64050) | (46960) |
| **Cash Flows from Financing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from borrowings on revolving credit facilities | 356300 | 308930 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of borrowings on revolving credit facilities | (289850) | (307580) |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt financing fees | (1260) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments to purchase common stock | (103320) | (19270) |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares surrendered upon exercise and vesting of equity awards to cover taxes | (2000) | (1760) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid | (6610) | (6630) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other financing activities | 290 | (2330) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used for financing activities | (46450) | (28640) |
| **Cash and Cash Equivalents:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) for the year | 6950 | (11820) |
| &nbsp;&nbsp;&nbsp;&nbsp;At beginning of year | 23070 | 34890 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At end of year | $30020 | $23070 |
| &nbsp;&nbsp;&nbsp;&nbsp;Supplemental disclosure of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $18760 | $18730 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes | $10630 | $11870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash property additions | $5170 | $— |

---

------

**Appendix I**

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting**

**Reported GAAP Financial Measures**

**(Unaudited - dollars in thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended<br>December 31,** | **Three months ended<br>December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Packaging** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $129260 | $123130 | $535540 | $512320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $14620 | $15060 | $68140 | $68120 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of and indefinite-lived intangible assets |  | 230 |  | 230 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 350 | 450 | 3270 | 2870 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $14970 | $15740 | $71410 | $71220 |
| **Specialty Products** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $26230 | $26600 | $110180 | $118480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $1710 | $(7470) | $4190 | $(1990) |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs |  | 8230 | 1240 | 8350 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $1710 | $760 | $5430 | $6360 |
| **Corporate Expenses** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $13610 | $(8390) | $(31030) | $(50960) |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating loss: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related (benefit) costs, net | (35800) |  | (27770) | 5510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate | 6500 | 960 | 6500 | 3220 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 240 | 430 | 630 | 3450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 780 | 1940 | 8280 | 3450 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 1980 | 1120 | 6280 | 4740 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine |  |  | (5380) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating loss | $(12690) | $(3940) | $(42490) | $(30590) |
| **TriMas Continuing Operations** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $155490 | $149730 | $645720 | $630800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $29940 | $(800) | $41300 | $15170 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Special Items to consider in evaluating operating profit | (25950) | 13360 | (6950) | 31820 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $3990 | $12560 | $34350 | $46990 |
| **Aerospace** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $100970 | $78320 | $396430 | $294210 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $12860 | $9420 | $67000 | $32020 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Third-party and other costs incurred related to strike |  | 1050 |  | 3390 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 3080 |  | 3080 | 60 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | (110) |  | 710 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate |  | 150 |  | 380 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs | 350 |  | 1550 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $16180 | $10620 | $72340 | $35850 |
| **Total Company** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $256460 | $228050 | $1042150 | $925010 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $42800 | $8620 | $108300 | $47190 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Special Items to consider in evaluating operating profit | (22630) | 14560 | (1610) | 35650 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $20170 | $23180 | $106690 | $82840 |

---

------

**Appendix I**

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting**

**Reported GAAP Financial Measures - Total Company**

**(Unaudited - dollars in thousands, except share and per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended<br> December 31,** | **Three months ended<br> December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Net income, Total Company** | $81700 | $5640 | $120140 | $24250 |
| **Special Items to consider in evaluating quality of net income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related (benefit) costs, net | (35800) |  | (27770) | 5510 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 1020 | 10620 | 13500 | 14670 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 3320 | 430 | 3710 | 3510 |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 1980 | 1120 | 6280 | 4740 |
| &nbsp;&nbsp;&nbsp;&nbsp;Third-party and other costs incurred related to strike |  | 1050 |  | 3390 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate | 6500 | 1110 | 6500 | 3600 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reversal of a contingent deferred purchase price liability |  | (2250) |  | (2250) |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment | (1540) |  | (1540) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on the sale of Arrow Engine |  |  | (5380) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax gain on the sale of Aerospace segment | (53900) |  | (53900) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs and other | 350 | 230 | 1650 | 240 |
| Amortization of acquisition-related intangible assets | 4380 | 4160 | 17320 | 16800 |
| Non-cash compensation expense | 3240 | (1090) | 10040 | 6960 |
| Income tax effect of net income adjustments<sup>(1)</sup> | 5000 | (3500) | (5300) | (13690) |
| &nbsp;&nbsp;**Adjusted net income** | $16250 | $17520 | $85250 | $67730 |
|  | **Three months ended<br>December 31,** | **Three months ended<br>December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Diluted earnings per share, Total Company** | $2.03 | $0.14 | $2.95 | $0.60 |
| Dilutive impact <sup>(2)</sup> |  |  |  | (0.01) |
| **Special Items to consider in evaluating quality of EPS:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related (benefit) costs, net | (0.89) |  | (0.68) | 0.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 0.03 | 0.26 | 0.33 | 0.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 0.08 | 0.01 | 0.09 | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 0.05 | 0.03 | 0.15 | 0.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Third-party and other costs incurred related to strike |  | 0.02 |  | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate | 0.16 | 0.03 | 0.16 | 0.09 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reversal of a contingent deferred purchase price liability |  | (0.05) |  | (0.05) |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment | (0.04) |  | (0.04) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on the sale of Arrow Engine |  |  | (0.13) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax gain on the sale of Aerospace segment | (1.34) |  | (1.32) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs and other | 0.01 | 0.01 | 0.04 | 0.01 |
| Amortization of acquisition-related intangible assets | 0.11 | 0.10 | 0.42 | 0.41 |
| Non-cash compensation expense | 0.08 | (0.03) | 0.25 | 0.17 |
| Income tax effect of net income adjustments<sup>(1)</sup> | 0.12 | (0.09) | (0.13) | (0.33) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjusted diluted EPS** | $0.40 | $0.43 | $2.09 | $1.65 |
| **Weighted-average shares outstanding** | 40148066 | 40956347 | 40790137 | 41055993 |

---

<sup>(1)</sup> Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the three and twelve month periods ended December 31, 2025, and 2024, the income tax effect of Special Items varied from the tax rate inherent in the Company's reported GAAP results, primarily as a result of certain discrete items that occurred during the period for GAAP reporting purposes.

<sup>(2)</sup> 330,279 shares were included in the as previously reported dilutive computation of earnings per share for the twelve months ended December 31, 2024.

------

**Appendix I**

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting** 

**Reported GAAP Financial Measures - Continuing Operations**

**(Unaudited - dollars in thousands, except share and per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended<br> December 31,** | **Three months ended<br> December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Income (loss) from continuing operations, as reported** | $72850 | $(3520) | $72310 | $(1950) |
| **Special Items to consider in evaluating quality of income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related (benefit) costs, net | (35800) |  | (27770) | 5510 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 1130 | 10620 | 12790 | 14670 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | (160) | 430 | (790) | 3450 |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 1980 | 1120 | 6280 | 4740 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate | 6500 | 960 | 6500 | 3220 |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment | (1540) |  | (1540) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on the sale of Arrow Engine |  |  | (5380) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax gain on the sale of Aerospace | (53900) |  | (53900) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other costs |  | 230 | 100 | 240 |
| Amortization of acquisition-related intangible assets | 1700 | 1590 | 6680 | 6520 |
| Non-cash compensation expense | 2870 | (1390) | 8410 | 5630 |
| Income tax effect of net income adjustments<sup>(1)</sup> | 5990 | (2950) | (1270) | (10430) |
| &nbsp;&nbsp;**Adjusted income from continuing operations** | $1620 | $7090 | $22420 | $31600 |
|  | **Three months ended<br> December 31,** | **Three months ended<br> December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Diluted earnings (loss) per share from continuing operations, as reported** | $1.81 | $(0.09) | $1.78 | $(0.05) |
| **Special Items to consider in evaluating quality of EPS from continuing operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related (benefit) costs, net | (0.89) |  | (0.68) | 0.13 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 0.03 | 0.26 | 0.31 | 0.36 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs |  | 0.01 | (0.02) | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 0.05 | 0.03 | 0.15 | 0.11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate | 0.16 | 0.02 | 0.16 | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment | (0.04) |  | (0.04) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on the sale of Arrow Engine |  |  | (0.13) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax gain on the sale of Aerospace | (1.34) |  | (1.32) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other costs |  | 0.01 |  | 0.01 |
| Amortization of acquisition-related intangible assets | 0.04 | 0.03 | 0.16 | 0.16 |
| Non-cash compensation expense | 0.07 | (0.03) | 0.21 | 0.14 |
| Income tax effect of net income adjustments<sup>(1)</sup> | 0.15 | (0.07) | (0.03) | (0.25) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjusted diluted EPS from continuing operations** | $0.04 | $0.17 | $0.55 | $0.77 |
| **Weighted-average shares outstanding** | 40148066 | 40956347 | 40790137 | 41055993 |

---

<sup>(1)</sup> Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the three and twelve month periods ended December 31, 2025, and 2024, the income tax effect of Special Items varied from the tax rate inherent in the Company's reported GAAP results, primarily as a result of certain discrete items that occurred during the period for GAAP reporting purposes.

------

**Appendix I**

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting**

**Reported GAAP Financial Measures - Discontinued Operations**

**(Unaudited - dollars in thousands, except share and per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended<br> December 31,** | **Three months ended<br> December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Income from discontinued operations, net of taxes** | $8850 | $9160 | $47830 | $26200 |
| **Special Items to consider in evaluating quality of income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | (110) |  | 710 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 3480 |  | 4500 | 60 |
| &nbsp;&nbsp;&nbsp;&nbsp;Third-party and other costs incurred related to strike |  | 1050 |  | 3390 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate |  | 150 |  | 380 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reversal of a contingent deferred purchase price liability |  | (2250) |  | (2250) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs and other | 350 |  | 1550 |  |
| Amortization of acquisition-related intangible assets | 2680 | 2570 | 10640 | 10280 |
| Non-cash compensation expense | 370 | 300 | 1630 | 1330 |
| Income tax effect of net income adjustments<sup>(1)</sup> | (990) | (550) | (4030) | (3260) |
| **Adjusted income from discontinued operations, net of taxes** | $14630 | $10430 | $62830 | $36130 |
|  | **Three months ended<br> December 31,** | **Three months ended<br> December 31,** | **Twelve months ended<br>December 31,** | **Twelve months ended<br>December 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Diluted earnings per share from discontinued operations** | $0.22 | $0.23 | $1.17 | $0.65 |
| Dilutive impact <sup>(2)</sup> |  |  |  | (0.01) |
| **Special Items to consider in evaluating quality of EPS:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs |  |  | 0.02 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 0.08 |  | 0.11 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Third-party and other costs incurred related to strike |  | 0.02 |  | 0.08 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate |  |  |  | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reversal of a contingent deferred purchase price liability |  | (0.05) |  | (0.05) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs and other | 0.01 |  | 0.04 |  |
| Amortization of acquisition-related intangible assets | 0.07 | 0.07 | 0.26 | 0.25 |
| Non-cash compensation expense | 0.01 | 0.01 | 0.04 | 0.03 |
| Income tax effect of net income adjustments<sup>(1)</sup> | (0.03) | (0.02) | (0.10) | (0.08) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjusted diluted EPS from discontinued operations** | $0.36 | $0.26 | $1.54 | $0.88 |
| **Weighted-average shares outstanding** | 40148066 | 40956347 | 40790137 | 41055993 |

---

<sup>(1)</sup> Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the three and twelve month periods ended December 31, 2025, and 2024, the income tax effect of Special Items varied from the tax rate inherent in the Company's reported GAAP results, primarily as a result of certain discrete items that occurred during the period for GAAP reporting purposes.

<sup>(2)</sup> 330,279 shares were included in the as previously reported dilutive computation of earnings per share for the twelve months ended December 31, 2024.

------

**Appendix I**

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting** 

**Reported GAAP Financial Measures - Total Company**

**(Unaudited - dollars in thousands)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended December 31,** | **Three months ended December 31,** | **Three months ended December 31,** | **Three months ended December 31,** | **Three months ended December 31,** | **Three months ended December 31,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **As reported** | **Special Items** | **As adjusted** | **As reported** | **Special Items** | **As adjusted** |
| Net cash provided by operating activities | $41520 | $6520 | $48040 | $27080 | $4650 | $31730 |
| Less: Capital expenditures | (4700) |  | (4700) | (14980) |  | (14980) |
| Free Cash Flow | $36820 | $6520 | $43340 | $12100 | $4650 | $16750 |
|  | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** | **Twelve months ended December 31,** |
|  | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
|  | **As reported** | **Special Items** | **As adjusted** | **As reported** | **Special Items** | **As adjusted** |
| Net cash provided by operating activities | $117450 | $18130 | $135580 | 63780 | $16490 | $80270 |
| Less: Capital expenditures | (48350) |  | (48350) | (50960) |  | (50960) |
| Free Cash Flow | $69100 | $18130 | $87230 | $12820 | $16490 | $29310 |

---

---

| | | |
|:---|:---|:---|
| | **December 31,<br>2025** | **December 31,<br>2024** |
| Long-term debt, net | $469170 | $398120 |
| Less: Cash and cash equivalents | 30020 | 23070 |
| Net Debt | $439150 | $375050 |

---

## Exhibit 99.2

**Exhibit 99.2**

**TriMas Corporation**

**Supplemental Business Segment Financial Information - As Previously Reported** 

**(Unaudited - dollars in thousands)**

---

| | | | |
|:---|:---|:---|:---|
| | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** |
| | **March 31** | **June 30** | **September 30** |
| **Packaging** | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $127570 | $143010 | $135700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $17240 | $19990 | $16290 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 580 | 440 | 1900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $17820 | $20430 | $18190 |
| **Aerospace** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $89210 | $103010 | $103240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $15070 | $20140 | $20200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs |  |  | 820 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs | 160 | 510 | 530 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $15230 | $20650 | $21550 |
| **Specialty Products** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $24890 | $28740 | $30320 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $(1150) | $1260 | $2370 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 1240 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $90 | $1260 | $2370 |
| **Corporate Expenses** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating loss | $(9380) | $(14260) | $(22270) |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating loss: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related costs |  |  | 8030 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 300 | 30 | 60 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 920 | 1440 | 1940 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 4720 | 2230 | 550 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine | (5300) |  | (80) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating loss | $(8740) | $(10560) | $(11770) |
| **Total Company** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $241670 | $274760 | $269260 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $21780 | $27130 | $16590 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Special Items to consider in evaluating operating profit | 2620 | 4650 | 13750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $24400 | $31780 | $30340 |

---

------

**TriMas Corporation**

**Supplemental Business Segment Financial Information - Recast for Aerospace Discontinued Operations**

**(Unaudited - dollars in thousands)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | |
| | **March 31** | **June 30** | **September 30** | **December 31** |<br>**Year ended December 31, 2025** |
| **Packaging** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $127570 | $143010 | $135700 | $129260 | $535540 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit | $17240 | $19990 | $16290 | $14620 | $68140 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 580 | 440 | 1900 | 350 | 3270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $17820 | $20430 | $18190 | $14970 | $71410 |
| **Specialty Products** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $24890 | $28740 | $30320 | $26230 | $110180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $(1150) | $1260 | $2370 | $1710 | $4190 |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating profit: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 1240 |  |  |  | 1240 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $90 | $1260 | $2370 | $1710 | $5430 |
| **Corporate Expenses** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $(8940) | $(13860) | $(21840) | $13610 | $(31030) |
| &nbsp;&nbsp;&nbsp;&nbsp;Special Items to consider in evaluating operating loss: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related costs |  |  | 8030 | (35800) | (27770) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability |  |  |  | 6500 | 6500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 300 | 30 | 60 | 240 | 630 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 920 | 1440 | 1940 | 1980 | 6280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 4720 | 2230 | 550 | 780 | 8280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine | (5300) |  | (80) |  | (5380) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating loss | $(8300) | $(10160) | $(11340) | $(12690) | $(42490) |
| **Total Company** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $152460 | $171750 | $166020 | $155490 | $645720 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating profit (loss) | $7150 | $7390 | $(3180) | $29940 | $41300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Special Items to consider in evaluating operating profit | 2460 | 4140 | 12400 | (25950) | (6950) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted operating profit | $9610 | $11530 | $9220 | $3990 | $34350 |

---

------

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting** 

**Reported GAAP Financial Measures - As Previously Reported**

**(Unaudited - dollars in thousands, except share and per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **Nine months ended September 30, 2025** |
| | **March 31** | **June 30** | **September 30** | **Nine months ended September 30, 2025** |
| **Income from continuing operations, as previously reported** | $12420 | $16720 | $9300 | $38440 |
| **Special Items to consider in evaluating quality of income from continuing operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related costs |  |  | 8030 | 8030 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 6540 | 2670 | 3270 | 12480 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs | 160 | 510 | 530 | 1200 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 300 | 30 | 60 | 390 |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 920 | 1440 | 1940 | 4300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-off of deferred financing fees | 100 |  |  | 100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine | (5300) |  | (80) | (5380) |
| Amortization of acquisition-related intangible assets | 4190 | 4350 | 4400 | 12940 |
| Non-cash compensation expense | 1490 | 2010 | 3300 | 6800 |
| Income tax effect of net income adjustments<sup>(1)</sup> | (1980) | (2660) | (5660) | (10300) |
| &nbsp;&nbsp;**Adjusted income from continuing operations** | $18840 | $25070 | $25090 | $69000 |
|  | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **Nine months ended September 30, 2025** |
|  | **March 31** | **June 30** | **September 30** | **Nine months ended September 30, 2025** |
| **Diluted earnings per share from continuing operations, as previously reported** | $0.30 | $0.41 | $0.23 | $0.94 |
| **Special Items to consider in evaluating quality of EPS from continuing operations:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related costs |  |  | 0.19 | 0.19 |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 0.16 | 0.06 | 0.08 | 0.30 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting costs | 0.01 | 0.01 | 0.01 | 0.03 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 0.01 |  |  | 0.01 |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 0.02 | 0.04 | 0.05 | 0.10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-off of deferred financing fees |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine | (0.13) |  |  | (0.13) |
| Amortization of acquisition-related intangible assets | 0.10 | 0.10 | 0.11 | 0.32 |
| Non-cash compensation expense | 0.04 | 0.05 | 0.08 | 0.17 |
| Income tax effect of net income adjustments<sup>(1)</sup> | (0.05) | (0.06) | (0.14) | (0.25) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjusted diluted EPS from continuing operations** | $0.46 | $0.61 | $0.61 | $1.68 |
| **Weighted-average shares outstanding** | 40969299 | 40929861 | 41113322 | 41004160 |

---

<sup>(1)</sup> Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the quarterly periods ended in 2025, the income tax effect of Special Items varied from the tax rate inherent in the Company's reported GAAP results, primarily as a result of certain discrete items that occurred during the period for GAAP reporting purposes.

------

**TriMas Corporation**

**Additional Information Regarding Special Items Impacting** 

**Reported GAAP Financial Measures - Recast for Aerospace Discontinued Operations**

**(Unaudited - dollars in thousands, except share and per share amounts)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Recast** | **Recast** | **Recast** | **As reported** | **As reported** |
| | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **Year ended December 31, 2025** |
| | **March 31** | **June 30** | **September 30** | **December 31** | **Year ended December 31, 2025** |
| **Income from continuing operations** | $1940 | $2410 | $(4890) | $72850 | $72310 |
| **Special Items to consider in evaluating quality of income from continuing operations:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related costs |  |  | 8030 | (35800) | (27770) |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 6540 | 2670 | 2450 | 1130 | 12790 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 300 | 30 | (960) | (160) | (790) |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 920 | 1440 | 1940 | 1980 | 6280 |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-off of deferred financing fees | 100 |  |  |  | 100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate |  |  |  | 6500 | 6500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment |  |  |  | (1540) | (1540) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine | (5300) |  | (80) |  | (5380) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax gain on the sale of Aerospace |  |  |  | (53900) | (53900) |
| Amortization of acquisition-related intangible assets | 1590 | 1680 | 1710 | 1700 | 6680 |
| Non-cash compensation expense | 1050 | 1610 | 2880 | 2870 | 8410 |
| Income tax effect of net income adjustments<sup>(1)</sup> | (1200) | (1790) | (4270) | 5990 | (1270) |
| &nbsp;&nbsp;**Adjusted income from continuing operations** | $5940 | $8050 | $6810 | $1620 | $22420 |
|  | **Recast** | **Recast** | **Recast** | **As reported** | **As reported** |
|  | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **2025 quarterly periods ended** | **Year ended December 31, 2025** |
|  | **March 31** | **June 30** | **September 30** | **December 31** | **Year ended December 31, 2025** |
| **Diluted earnings per share from continuing operations** | $0.05 | $0.06 | $(0.12) | $1.81 | $1.78 |
| **Special Items to consider in evaluating quality of EPS from continuing operations:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Asbestos-related costs |  |  | 0.20 | (0.89) | (0.68) |
| &nbsp;&nbsp;&nbsp;&nbsp;Business restructuring and severance costs | 0.16 | 0.06 | 0.06 | 0.03 | 0.31 |
| &nbsp;&nbsp;&nbsp;&nbsp;M&A diligence and transaction costs | 0.01 |  | (0.02) |  | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;System implementation costs | 0.02 | 0.04 | 0.05 | 0.05 | 0.15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Write-off of deferred financing fees |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in environmental liability estimate |  |  |  | 0.16 | 0.16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency translation adjustment |  |  |  | (0.04) | (0.04) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of Arrow Engine | (0.13) |  |  |  | (0.13) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred tax gain on the sale of Aerospace |  |  |  | (1.34) | (1.32) |
| Amortization of acquisition-related intangible assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.16 |
| Non-cash compensation expense | 0.03 | 0.04 | 0.07 | 0.07 | 0.21 |
| Income tax effect of net income adjustments<sup>(1)</sup> | (0.03) | (0.04) | (0.11) | 0.15 | (0.03) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjusted diluted EPS from continuing operations** | $0.15 | $0.20 | $0.17 | $0.04 | $0.55 |
| **Weighted-average shares outstanding** | 40969299 | 40929861 | 41113322 | 40148066 | 40790137 |

---

<sup>(1)</sup> Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the quarterly periods ended in 2025, the income tax effect of Special Items varied from the tax rate inherent in the Company's reported GAAP results, primarily as a result of certain discrete items that occurred during the period for GAAP reporting purposes.